Transcription of Tadalafil once daily and extracorporeal shock wave therapy ...
{{id}} {{{paragraph}}}
Example: biology
Tadalafil once daily and extracorporeal shock wave therapy ...
ORIGINAL ARTICLET adalafil once daily and extracorporeal shock wavetherapy in the management of patients with Peyronie sdisease and erectile dysfunction: results from a prospectiverandomized trialA. Palmieri, C. Imbimbo, M. Creta, P. Verze, F. Fusco and V. MironeDepartment of Urology, University Federico II of Naples, Naples, ItalyIntroductionPeyronie s disease (PD) is a localized disorder of the con-nective tissue involving the penile tunica albuginea andthe surrounding areolar spaces that typically evolves infibrotic plaques [Bivalacquaet al.(2000)]. Patients pres-ent with three, occasionally simultaneous, chief com-plaints: a palpable plaque, painful erections and a peniledeformity [Palmieriet al.(2009)]. Moreover, PD is asso-ciated with erectile dysfunction (ED) in a percentage ofpatients ranging from 18 to 80% [Weidneret al.]
Extracorporeal shock wave therapy improves erectile function in patients with Peyronie’s disease. However, erectile dysfunction still persists in many cases. We aimed to investigate the effects of extracorporeal shock wave therapy plus tadalafil 5 mg once daily in the management of patients with Peyronie’s disease
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Extracorporeal shock wave therapy, Therapy, Clinically Relevant, Evaluation of Extracorporeal Shock Wave Therapy for, Shock wave, Extracorporeal Shock Wave Therapy for, Extracorporeal Shock Wave Therapy: Current Evidence, Shock, Extracorporeal Shock Wave Therapy ESWT, Extracorporeal shockwave therapy